Contract 36C26026F0023
Napo Pharmaceuticals Inc · Department Of Veterans Affairs · October 1, 2025
Napo Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on October 1, 2025 for $76,000 of work in pharmaceutical preparation manufacturing. Performance is in San Francisco, CA. This is a task or delivery order issued under parent IDIQ 36F79723D0158. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026.
Contract details
- PIID
- 36C26026F0023
- Parent IDIQ
- 36F79723D0158
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- San Francisco, CA
- First action
- October 1, 2025
- Latest action
- March 18, 2026
Description
PHARM - MYTESI. INCREASED UTILIZATION
Modification timeline
-
March 18, 2026Mod P00001 · Funding Only Action$76.1K
-
October 1, 2025Base awardPHARM - MYTESI$32.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26026F0023?
Contract 36C26026F0023 is a federal contract awarded to Napo Pharmaceuticals Inc by Department Of Veterans Affairs on October 1, 2025 for $76,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C26026F0023?
Napo Pharmaceuticals Inc won contract 36C26026F0023 from Department Of Veterans Affairs.
How much is contract 36C26026F0023 worth?
Contract 36C26026F0023 has obligated $76,000 to date.